CORE OUTCOME SET FOR CLINICAL TRIALS ON CORONAVIRUS DISEASE 2019 (COS-COVID)


Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice

Background/Objectives: Novel mRNA vaccines have been successfully utilized to curtail the SARS-CoV-2 pandemic.However, the immunology underlying CoV2 vaccinations, particularly with repeated boosting, has not been properly characterized due to limitations in the preclinical modeling of SARS-CoV-2 infection/vaccinations as well as constantly changin

read more

Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development

Abstract Candida albicans is the most abundant fungal species in oral cavity.As a smart opportunistic pathogen, it increases the virulence by switching its forms from yeasts to hyphae and becomes the major pathogenic agent for oral candidiasis.However, the overuse of current clinical antifungals and lack of new types of drugs highlight the challeng

read more